应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
休市中 02-13 16:08:09
10.110
-0.030
-0.30%
最高
10.110
最低
9.900
成交量
4,544万
今开
10.080
昨收
10.140
日振幅
2.07%
总市值
1,165亿
流通市值
1,165亿
总股本
115.22亿
成交额
4.56亿
换手率
0.39%
流通股本
115.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
6.63亿“抄底”,石药集团拿下知名药企控股权|重生局
北京药研汇 · 02-13 18:13
6.63亿“抄底”,石药集团拿下知名药企控股权|重生局
石药集团02月13日主力净流出2271.5万元 散户资金买入
市场透视 · 02-13 16:16
石药集团02月13日主力净流出2271.5万元 散户资金买入
石药巨石生物SYS6010启动Ⅲ期临床 适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌
新浪财经 · 02-12 18:03
石药巨石生物SYS6010启动Ⅲ期临床 适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌
阿斯利康中国去年收入66亿美元创新高 口服减肥药将进三期临床
澎湃新闻 · 02-11 22:06
阿斯利康中国去年收入66亿美元创新高 口服减肥药将进三期临床
每日卖空追踪 | 石药集团 02月11日卖空量成交948.4万股,卖空比例为9.47%
市场透视 · 02-11 16:30
每日卖空追踪 | 石药集团 02月11日卖空量成交948.4万股,卖空比例为9.47%
石药集团02月10日获主力大幅加仓1.9亿元
市场透视 · 02-10
石药集团02月10日获主力大幅加仓1.9亿元
创新药概念股普遍走高 石药集团涨超7%药明生物涨超5%
新浪港股 · 02-10
创新药概念股普遍走高 石药集团涨超7%药明生物涨超5%
创新药概念震荡反弹 高增长潜力概念股出炉
腾讯自选股综合 · 02-10
创新药概念震荡反弹 高增长潜力概念股出炉
6天6阳,港股通医疗、港股通创新药正加速回暖!
每日经济新闻 · 02-10
6天6阳,港股通医疗、港股通创新药正加速回暖!
石药集团再涨近5%公司与阿斯利康合作再升级有望加速长效多肽药物全球布局
动脉网 · 02-10
石药集团再涨近5%公司与阿斯利康合作再升级有望加速长效多肽药物全球布局
港股异动 | 石药集团(01093)涨超3% 机构看好公司未来在EGFR ADC及研发平台将有更多对外授权合作机会
智通财经 · 02-09
港股异动 | 石药集团(01093)涨超3% 机构看好公司未来在EGFR ADC及研发平台将有更多对外授权合作机会
【券商聚焦】东北证券首予石药集团“买入”评级 指与阿斯利康合作升级加速全球化布局
金吾财讯 · 02-09
【券商聚焦】东北证券首予石药集团“买入”评级 指与阿斯利康合作升级加速全球化布局
生物类似药,卷土重来
医前沿 · 02-07
生物类似药,卷土重来
康诺亚 TSLP 单抗启动新 III 期,石药拥有权益
丁香园 Insight 数据库 · 02-05
康诺亚 TSLP 单抗启动新 III 期,石药拥有权益
每日卖空追踪 | 石药集团 02月05日卖空量成交747.8万股,卖空比例为9.6%
市场透视 · 02-05
每日卖空追踪 | 石药集团 02月05日卖空量成交747.8万股,卖空比例为9.6%
东方证券:替尔泊肽加冕新“药王” 未来减重药物商业价值将快速释放
智通财经 · 02-05
东方证券:替尔泊肽加冕新“药王” 未来减重药物商业价值将快速释放
4.56个亿!S司给727名员工发钱!
体外诊断网 · 02-05
4.56个亿!S司给727名员工发钱!
石药集团185亿美元合作背后
YOUNG财经 漾财经 · 02-04
石药集团185亿美元合作背后
石药集团02月04日主力净流出7504.9万元 散户资金买入
市场透视 · 02-04
石药集团02月04日主力净流出7504.9万元 散户资金买入
【券商聚焦】招银国际维持石药集团(01093)“买入”评级 指BD交易将成为盈利增长的关键可持续驱动力
金吾财讯 · 02-03
【券商聚焦】招银国际维持石药集团(01093)“买入”评级 指BD交易将成为盈利增长的关键可持续驱动力
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":10.11,"timestamp":1770970089000,"preClose":10.14,"halted":0,"volume":45442545,"delay":0,"changeRate":-0.0029585798816569166,"floatShares":11522000000,"shares":11522000000,"eps":0.4175885124216319,"marketStatus":"休市中","change":-0.03,"latestTime":"02-13 16:08:09","open":10.08,"high":10.11,"low":9.9,"amount":455629427,"amplitude":0.02071,"askPrice":10.11,"askSize":464000,"bidPrice":10.1,"bidSize":494000,"shortable":3,"etf":0,"ttmEps":0.40119723632369725,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771205400000},"marketStatusCode":7,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":10.14,"dividendRate":0.023719,"openAndCloseTimeList":[[1770946200000,1770955200000],[1770958800000,1770969600000]],"volumeRatio":0.472506384016206,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.5232,"impliedVolPercentile":0.4859},"requestUrl":"/m/hq/s/01093/wiki","defaultTab":"wiki","newsList":[{"id":"2611169820","title":"6.63亿“抄底”,石药集团拿下知名药企控股权|重生局","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169820","media":"北京药研汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611169820?lang=zh_cn&edition=full","pubTime":"2026-02-13 18:13","pubTimestamp":1770977633,"startTime":"0","endTime":"0","summary":"近日,此前一度面临退市风险的湖南景峰医药正式官宣破产重整,其重整计划取得重要突破。根据当日公布的重整计划草案,石药控股集团有限公司作为牵头投资人,联合其余18家重整参与方,将共同受让景峰医药转增的879,774,351股股份,总投资额约20.61亿元。石药集团一出手就是6.63亿,直接拿下控股权。根据重整计划草案,仅石药集团受让股份的对价就达6.63亿元,后续可能还需持续投入资源,帮助该公司恢复经营活力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021319574595410d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021319574595410d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","LU1152091168.USD","LU0326950275.SGD","LU0501845795.SGD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU1008478684.HKD","IE0008368742.USD","01093","LU0880133367.SGD","LU1960683339.HKD","LU1226287875.USD","LU1226288253.USD","LU0315179316.USD","LU1807302812.USD","LU1813983027.USD","LU1226287529.USD","LU1328277881.USD","LU0314109678.HKD","LU2039709279.SGD","BK1521","LU1152091754.HKD","SG9999004220.SGD","LU1226287792.SGD","IE00B543WZ88.USD","LU1226288170.HKD","LU0067412154.USD","IE00BZ08YT58.USD","BK1191","BK1515","LU1951186391.HKD","HK0000165453.HKD","IE00B031HY20.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU0072913022.USD"],"gpt_icon":0},{"id":"2611169826","title":"石药集团02月13日主力净流出2271.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611169826?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:16","pubTimestamp":1770970560,"startTime":"0","endTime":"0","summary":"02月13日, 石药集团股价跌0.30%,报收10.11元,成交金额4.6亿元,换手率0.39%,振幅2.07%,量比0.47。石药集团今日主力资金净流出2271.5万元,上一交易日主力净流入3004.4万元。该股近5个交易日上涨5.69%,主力资金累计净流入2.6亿元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入6.6亿元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213162207a6f6d6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213162207a6f6d6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","BK1521","BK1191","LU1960683339.HKD","LU1807302812.USD","LU2039709279.SGD","IE00B543WZ88.USD","SG9999004220.SGD","LU1226288170.HKD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1813983027.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","IE0008369823.USD","LU0067412154.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU0140636845.USD","LU0326950275.SGD","HK0000165453.HKD","IE0008368742.USD","LU0072913022.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1226287792.SGD","LU1152091168.USD","LU1226287875.USD","LU0314109678.HKD","LU1226287529.USD","LU1152091754.HKD","LU0880133367.SGD","BK1515","LU0315179316.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2611906562","title":"石药巨石生物SYS6010启动Ⅲ期临床 适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2611906562","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611906562?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:03","pubTimestamp":1770890580,"startTime":"0","endTime":"0","summary":"本次试验主要目的为评价SYS6010对比研究者选择的单药化疗在经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌参与者中的有效性;次要目的为进一步评价有效性、评价安全性、评价PK特征、评价免疫原性特征及评价EGFR蛋白表达水平与疗效相关性。SYS6010为生物制品,适应症为经至少一线系统性治疗失败的局部晚期或转移性/复发食管鳞癌。食管鳞癌是食管癌主要亚型,晚期患者预后差,一线治疗失败后缺乏有效疗法,严重威胁患者生存。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212185311a6f3170b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212185311a6f3170b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0008369823.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU1152091168.USD","IE00B543WZ88.USD","LU1226287792.SGD","HK0000165453.HKD","IE00BZ08YS42.EUR","LU0067412154.USD","IE00BZ08YR35.GBP","LU0140636845.USD","LU1813983027.USD","SG9999004220.SGD","BK1191","LU1226287529.USD","LU0314109678.HKD","IE00B031HY20.USD","LU1226288253.USD","LU0880133367.SGD","LU1152091754.HKD","LU1993786604.SGD","LU1951186391.HKD","LU1807302812.USD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU2039709279.SGD","LU0315179316.USD","BK1515","LU0326950275.SGD","IE0008368742.USD","BK1521","LU1226288170.HKD","LU1008478684.HKD","01093","IE00B5MMRT66.SGD","LU1328277881.USD"],"gpt_icon":0},{"id":"2610997527","title":"阿斯利康中国去年收入66亿美元创新高 口服减肥药将进三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2610997527","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610997527?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:06","pubTimestamp":1770818785,"startTime":"0","endTime":"0","summary":"当地时间2月10日,阿斯利康发布2025年业绩,全年总营收587.39亿美元,同比增长8%,其中产品收入586.4亿美元,同比增长10%。从地区分布来看,2025年美国市场收入254.5亿美元,同比增长10%,新兴市场收入153.03亿美元,同比增长14%,其中阿斯利康中国2025年总营收为66.54亿美元,创历史新高,同比增长4%,占据阿斯利康全球市场份额的11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211221813a6ef5edf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211221813a6ef5edf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0880133367.SGD","LU1328277881.USD","BK1521","01093","LU1993786604.SGD","LU1226287875.USD","LU0501845795.SGD","LU1807302812.USD","IE0008368742.USD","LU1813983027.USD","LU1008478684.HKD","LU1226288253.USD","LU1152091168.USD","LU1226287529.USD","IE00B031HY20.USD","LU0326950275.SGD","LU1226287792.SGD","LU2039709279.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU1152091754.HKD","LU0067412154.USD","BK1515","IE0008369823.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","LU0315179316.USD","LU1226288170.HKD","LU1951186391.HKD","BK1191","HK0000165453.HKD","IE00B543WZ88.USD","LU0140636845.USD","SG9999004220.SGD","LU0072913022.USD"],"gpt_icon":0},{"id":"2610975659","title":"每日卖空追踪 | 石药集团 02月11日卖空量成交948.4万股,卖空比例为9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610975659","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610975659?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798619,"startTime":"0","endTime":"0","summary":"石药集团北京时间02月11日,涨1.55%,卖空量成交948.4万股,较上一交易日减少63.45%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163210a6ee1bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163210a6ee1bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1960683339.HKD","LU1226287529.USD","LU0072913022.USD","IE0008368742.USD","LU1807302812.USD","LU2039709279.SGD","LU1993786604.SGD","SG9999004220.SGD","LU0501845795.SGD","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1226287792.SGD","LU0314109678.HKD","IE0008369823.USD","IE00B031HY20.USD","LU1008478684.HKD","LU1226288170.HKD","LU1813983027.USD","LU0326950275.SGD","IE00B543WZ88.USD","BK1191","LU1328277881.USD","BK1521","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01093","BK1515","IE00B5MMRT66.SGD","LU0140636845.USD","LU0315179316.USD","LU0067412154.USD","LU0880133367.SGD","LU1152091168.USD","HK0000165453.HKD","LU1226287875.USD","LU1951186391.HKD","LU1226288253.USD"],"gpt_icon":0},{"id":"2610271216","title":"石药集团02月10日获主力大幅加仓1.9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610271216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610271216?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711347,"startTime":"0","endTime":"0","summary":"02月10日, 石药集团股价涨5.52%,报收10.32元,成交金额15.5亿元,换手率1.30%,振幅8.69%,量比1.35。石药集团今日主力资金净流入1.9亿元,连续3日净流入,上一交易日主力净流入7663.0万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为55.00%,平均涨幅为3.99%。该股近5个交易日上涨3.34%,主力资金累计净流入2.1亿元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入7.6亿元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161953a6e99ab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161953a6e99ab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1008478684.HKD","LU0501845795.SGD","LU1807302812.USD","HK0000165453.HKD","BK1191","LU1813983027.USD","IE0008369823.USD","LU1951186391.HKD","LU1226287792.SGD","LU0880133367.SGD","BK1521","LU0072913022.USD","LU0314109678.HKD","LU0140636845.USD","LU0315179316.USD","IE0008368742.USD","LU2039709279.SGD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","01093","LU1226287875.USD","IE00B031HY20.USD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287529.USD","SG9999004220.SGD","LU1226288253.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0067412154.USD"],"gpt_icon":0},{"id":"2610943736","title":"创新药概念股普遍走高 石药集团涨超7%药明生物涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610943736","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610943736?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:34","pubTimestamp":1770694440,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 创新药概念股午前普遍走高,截至发稿,石药集团(01093)上涨7.16%,报10.48港元;药明生物(02269)上涨5.54%,报40.36港元;康诺亚-B(02162)上涨5.45%,报60.95港元;信达生物(01801)上涨5.15%,报89.8港元;再鼎医药(09688)上涨4.9%,报14.76港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-10/doc-inhmiaep8549540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0039217434.USD","LU0327786744.USD","LU0880133367.SGD","LU1807302812.USD","BK1521","LU0320764599.SGD","LU0326950275.SGD","LU1152091754.HKD","LU0456827905.SGD","IE00B031HY20.USD","06978","LU0359201612.USD","LU0359202008.SGD","LU3063872942.SGD","LU0588546209.SGD","SG9999002562.SGD","LU2039709279.SGD","02269","LU0708995583.HKD","BK1574","BK1161","LU1794554557.SGD","LU0417516902.SGD","159992","LU1152091168.USD","BK1576","LU0456846285.SGD","LU0348825331.USD","LU1688375341.USD","LU0516423174.USD","LU0516423091.SGD","BK1610","LU1242518931.SGD","IE00B543WZ88.USD","BK1515","LU1993786604.SGD","LU1226287529.USD","LU1813983027.USD","LU1242518857.USD","LU0979878070.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU0501845795.SGD","01093","LU0052750758.USD","BK1141","LU1226287875.USD","LU1880383366.USD","IE0008368742.USD","BK1191"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹,广生堂涨超10%,此前万邦德涨停,尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出,经历短期波动消化后,创新药板块已显现企稳回暖迹象。整体上,国金证券认为创新药前期回调较为充分,向上产业趋势明确,催化近期密集,继续看好板块投资机会。从未来增长潜力来看,多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","BK1515","02196","01548","06978","BK1161","BK1583","01513","00512","01801","01877","06160","06185","03692","BK1574","00867","01276","02096","00013","02269","01952","02228","01177"],"gpt_icon":0},{"id":"2610627102","title":"6天6阳,港股通医疗、港股通创新药正加速回暖!","url":"https://stock-news.laohu8.com/highlight/detail?id=2610627102","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610627102?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:35","pubTimestamp":1770690959,"startTime":"0","endTime":"0","summary":"2月份以来,港股医药、医疗以一波强势连阳行情,持续修复失地。热门ETF方面,2月10日,港股通创新药ETF、港股通医疗ETF早盘悉数涨逾2%,其中,港股通创新药ETF涨幅更是逼近3%。港股通创新药ETF及其场外联接基金,100%布局创新药研发类公司,前十大权重股占比超73%,龙头属性突出。港股通医疗ETF华宝,锚定医疗创新,囊括脑机接口、AI医疗、互联网药店等热点概念,同时覆盖创新药全产业链龙头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210103758a4917721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210103758a4917721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1807302812.USD","IE00BZ08YR35.GBP","BK1161","LU2039709279.SGD","LU1328277881.USD","LU0140636845.USD","LU1152091754.HKD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1226287529.USD","LU0067412154.USD","IE00BZ08YT58.USD","LU1813983027.USD","BK1515","IE00B5MMRT66.SGD","LU0315179316.USD","HK0000165453.HKD","LU0072913022.USD","LU1226288253.USD","LU1008478684.HKD","LU0880133367.SGD","06978","BK1191","IE00B543WZ88.USD","LU0326950275.SGD","IE0008369823.USD","LU1226288170.HKD","LU1951186391.HKD","IE0008368742.USD","LU0314109678.HKD","LU1152091168.USD","IE00B031HY20.USD","LU1960683339.HKD","SG9999004220.SGD","BK1521","01093","LU1226287875.USD","LU1226287792.SGD","BK1574"],"gpt_icon":0},{"id":"2610627107","title":"石药集团再涨近5%公司与阿斯利康合作再升级有望加速长效多肽药物全球布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2610627107","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610627107?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:24","pubTimestamp":1770690240,"startTime":"0","endTime":"0","summary":"石药集团(01093)股价再涨近5%,截至发稿涨4.7%,报10.24港元,成交额4.86亿港元。近日,石药集团宣布与阿斯利康就创新长效多肽药物开发签订战略合作与授权协议,东北证券认为此次BD交易金额超预期,彰显阿斯利康对石药集团长效多肽与AI制药技术平台的高度认可与长期看好。此次合作标志着双方合作的再升级,有望加速石药集团长效多肽药物的全球布局。合作围绕石药专有的缓释给药技术平台及多肽药物AI发现平台展开,其长效技术可实现多肽药物缓释,多肽药物AI发现平台则能针对药物靶点快速设计及筛选候选分子,并在多个维度进行系统优化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210103119a49170bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210103119a49170bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287529.USD","LU1993786604.SGD","LU1152091754.HKD","BK1191","HK0000165453.HKD","LU0140636845.USD","01093","SG9999004220.SGD","LU1807302812.USD","LU0315179316.USD","IE00BZ08YR35.GBP","BK1515","LU0314109678.HKD","LU1226288170.HKD","LU1226288253.USD","LU1813983027.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1328277881.USD","LU0072913022.USD","IE00BZ08YT58.USD","LU1960683339.HKD","IE00B031HY20.USD","IE0008369823.USD","LU1226287792.SGD","LU0326950275.SGD","LU0880133367.SGD","BK1521","LU1951186391.HKD","IE0008368742.USD","LU0501845795.SGD","LU2039709279.SGD","IE00B543WZ88.USD","LU0067412154.USD","LU1226287875.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2610502918","title":"港股异动 | 石药集团(01093)涨超3% 机构看好公司未来在EGFR ADC及研发平台将有更多对外授权合作机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502918","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610502918?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:35","pubTimestamp":1770604509,"startTime":"0","endTime":"0","summary":"消息面上,汇丰研究发布研究报告指出,石药集团股价年初至今累计上涨约9%,在1月30日公布与阿斯利康的合作前已升14%,目前认为其估值仍然吸引,并憧憬未来在EGFR ADC及研发平台将有更多对外授权合作机会,计及预付款及上季销售轻微改善的预期,将2025至2027年收入预测上调3%至11%。该行并将石药集团2025至2027年净利润预测上调7%至18%,认为对外授权收入的增长已能抵销药品集中带量采购政策所带来的负面影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","LU1152091168.USD","LU1951186391.HKD","LU0501845795.SGD","LU1813983027.USD","LU0315179316.USD","ADC","LU2039709279.SGD","BK4231","VT","LU1328277881.USD","LU0880133367.SGD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1960683339.HKD","LU1008478684.HKD","IE00BZ08YT58.USD","BK1521","IE00B031HY20.USD","BK4588","LU1807302812.USD","LU1993786604.SGD","LU0067412154.USD","IE0008369823.USD","LU1226287529.USD","LU0072913022.USD","VXUS","BK1191","LU1226288170.HKD","BK1515","LU1226287792.SGD","SG9999004220.SGD","BK4080","HK0000165453.HKD","IE0008368742.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0314109678.HKD","BK4585","LU1152091754.HKD","LU1226288253.USD","LU0140636845.USD","01093"],"gpt_icon":0},{"id":"2610502281","title":"【券商聚焦】东北证券首予石药集团“买入”评级 指与阿斯利康合作升级加速全球化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502281","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610502281?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:01","pubTimestamp":1770602516,"startTime":"0","endTime":"0","summary":"金吾财讯|东北证券发布研报指,石药集团与阿斯利康签订战略研发合作与授权协议,围绕长效多肽与AI制药技术平台展开合作,潜在交易总金额达185亿美元。研报指出,公司核心技术平台实现突破,其缓释给药技术可使多肽药物给药间隔达每月一次,多肽药物AI发现平台能快速设计优化候选分子。公司构建覆盖抗肿瘤、心脑血管等核心赛道的研发格局,多项资产获跨国药企认可。给予“买入”评级,风险提示包括研发进展不及预期等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209102357a6e400a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209102357a6e400a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093"],"gpt_icon":0},{"id":"2609527492","title":"生物类似药,卷土重来","url":"https://stock-news.laohu8.com/highlight/detail?id=2609527492","media":"医前沿","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609527492?lang=zh_cn&edition=full","pubTime":"2026-02-07 20:31","pubTimestamp":1770467497,"startTime":"0","endTime":"0","summary":"在当前创新药高举高打的热潮下,生物类似药似乎在角落中再次萌芽,迎来了新的生机。粗略检索CDE受理品种信息,国内生物药3.3类生物类似药申报数量达到了26项,自2025年以来增速显著。这些都是生物类似药研发的主流企业,都有多款产品获批上市。成都康弘通过布局IL-4R和PD-1两项爆款生物类似药,快速重启生物新药研发,与两款双抗双毒素ADC创新管线交相辉映,在创新药的不确定性中寻找确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207204301a4881bd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207204301a4881bd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","HK0000165453.HKD","LU0502904849.HKD","LU2097828805.USD","BK1583","LU2097828714.EUR","LU2242644610.SGD","01093","01801","BK1161","LU2328871848.SGD","LU2488822045.USD","LU1969619763.USD","LU2097828474.EUR","LU2097828631.EUR","LU0455707207.USD","LU2097828557.USD","02696"],"gpt_icon":0},{"id":"2609133589","title":"康诺亚 TSLP 单抗启动新 III 期,石药拥有权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2609133589","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609133589?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:12","pubTimestamp":1770282749,"startTime":"0","endTime":"0","summary":"TSLP 是炎症级联反应的启动因子之一,抑制 TSLP 可以从炎症发生的早期进行干预,阻止免疫细胞释放促炎细胞因子。其中哮喘已经推进至 III 期临床研究。2021 年 11 月,康诺亚与石药集团达成合作,将 CM326 在中重度哮喘和慢性阻塞性肺病等呼吸系统疾病开发及商业化权益独家授予后者。2024 年 11 月,康诺亚同意扩大授予石药集团的特许权使用领域至所有适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020519483897a50562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020519483897a50562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1008478684.HKD","BK1515","LU0067412154.USD","LU1152091168.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1226287529.USD","LU1993786604.SGD","LU1226287875.USD","02162","IE00B031HY20.USD","LU0314109678.HKD","LU1226288253.USD","IE0008369823.USD","LU0501845795.SGD","IE0008368742.USD","LU1813983027.USD","BK1574","LU0326950275.SGD","01093","IE00BZ08YT58.USD","LU1152091754.HKD","LU0072913022.USD","LU1226288170.HKD","LU1807302812.USD","HK0000165453.HKD","BK1583","IE00BZ08YS42.EUR","LU0880133367.SGD","LU1226287792.SGD","SG9999004220.SGD","LU1951186391.HKD","BK1191","LU2039709279.SGD","BK1521","LU1960683339.HKD","LU1328277881.USD","BK1587","LU0315179316.USD","LU0140636845.USD","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2609370732","title":"每日卖空追踪 | 石药集团 02月05日卖空量成交747.8万股,卖空比例为9.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609370732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609370732?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:30","pubTimestamp":1770280218,"startTime":"0","endTime":"0","summary":"石药集团北京时间02月05日,涨0.52%,卖空量成交747.8万股,较上一交易日减少60.02%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163349a47f5fc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163349a47f5fc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","LU1152091168.USD","LU1951186391.HKD","LU0501845795.SGD","LU1813983027.USD","LU0315179316.USD","LU2039709279.SGD","LU1328277881.USD","LU0880133367.SGD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1960683339.HKD","LU1008478684.HKD","IE00BZ08YT58.USD","BK1521","IE00B031HY20.USD","LU1807302812.USD","LU1993786604.SGD","LU0067412154.USD","IE0008369823.USD","LU1226287529.USD","LU0072913022.USD","BK1191","LU1226288170.HKD","BK1515","LU1226287792.SGD","SG9999004220.SGD","HK0000165453.HKD","IE0008368742.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0314109678.HKD","LU1152091754.HKD","LU1226288253.USD","LU0140636845.USD","01093"],"gpt_icon":0},{"id":"2609273347","title":"东方证券:替尔泊肽加冕新“药王” 未来减重药物商业价值将快速释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2609273347","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609273347?lang=zh_cn&edition=full","pubTime":"2026-02-05 13:38","pubTimestamp":1770269908,"startTime":"0","endTime":"0","summary":"当前,MNC已将减重视为核心的战略要地,大额BD和并购频现,今年催化密集。东方证券主要观点如下:替尔泊肽加冕“药王”,减重药物将霸榜2026年2月4日,礼来发布2025年业绩,替尔泊肽全年销售365.07亿美元,加冕2025年全球“药王”,并有望多年蝉联。据Evaluate预测,到2030年全球销售额前十药物中约半数为GLP-1类药物。减重BD未停,新方向需求将起去年末以来,减重领域交易仍在持续。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","BK1147","LU1960683339.HKD","LU1226288170.HKD","BK1191","BK1161","LU0501845795.SGD","LU1813983027.USD","LU0880133367.SGD","LU1226288253.USD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1226287792.SGD","SG9999004220.SGD","LU1008478684.HKD","LU1951186391.HKD","BK1564","LU1993786604.SGD","01093","BK1521","IE0008368742.USD","LU0067412154.USD","LU0314109678.HKD","LU1152091168.USD","IE00B5MMRT66.SGD","BK0028","IE00B031HY20.USD","LU0315179316.USD","03958","BK1515","BK0012","BK0188","LU1807302812.USD","01672","600958","LU0326950275.SGD","LU0140636845.USD","LU1226287529.USD","BK1574","BK0276","IE00BZ08YR35.GBP","LU1328277881.USD","BK0183","IE00BZ08YT58.USD","LU0072913022.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2609707683","title":"4.56个亿!S司给727名员工发钱!","url":"https://stock-news.laohu8.com/highlight/detail?id=2609707683","media":"体外诊断网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609707683?lang=zh_cn&edition=full","pubTime":"2026-02-05 12:07","pubTimestamp":1770264466,"startTime":"0","endTime":"0","summary":"来源:企业公告 整理:体外诊断网1月23日,港股上市公司石药集团发布自愿公告,宣布根据其限制性股份奖励计划,向集团内727名获选雇员无偿授予合共46,462,500股限制性股份。以授出日收市价每股9.81港元计算,此次授予股份总价值约4.56亿港元。本次授予的奖励股份数量约占公司已发行股份总数的0.4%。石药集团强调,该计划属于《上市规则》第17章所规范的涉及现有股份的股份计划,相关披露符合监管要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205123959953fe932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205123959953fe932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU1226287792.SGD","LU1226288170.HKD","LU0315179316.USD","LU1152091754.HKD","LU1951186391.HKD","LU1328277881.USD","IE00BZ08YT58.USD","LU1008478684.HKD","LU0067412154.USD","IE00B031HY20.USD","01093","LU1226287529.USD","LU1807302812.USD","LU1960683339.HKD","BK1521","IE0008368742.USD","LU0140636845.USD","LU1813983027.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU0314109678.HKD","LU1226287875.USD","LU0501845795.SGD","SG9999004220.SGD","IE00B543WZ88.USD","LU0072913022.USD","LU1993786604.SGD","LU1226288253.USD","BK1191","IE0008369823.USD","LU0326950275.SGD","LU0880133367.SGD","LU2039709279.SGD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1152091168.USD"],"gpt_icon":0},{"id":"2609539158","title":"石药集团185亿美元合作背后","url":"https://stock-news.laohu8.com/highlight/detail?id=2609539158","media":"YOUNG财经 漾财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609539158?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:35","pubTimestamp":1770204920,"startTime":"0","endTime":"0","summary":"石药集团185亿美元合作背后王琳1月30日早间,石药集团重磅宣布,与阿斯利康签订战略研发合作与授权协议,以利用石药集团专有的缓释给药技术平台及多肽药物AI发现平台,开发创新长效多肽药物。交易总额高达185亿美元。2025年6月,石药集团与阿斯利康达成一项潜在金额超53亿美元的战略合作,聚焦AI驱动的新型口服小分子候选药物开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020421474697a4ddc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020421474697a4ddc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0315179316.USD","BK1515","LU1152091754.HKD","LU1807302812.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","LU1008478684.HKD","LU0326950275.SGD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1328277881.USD","LU0501845795.SGD","LU0072913022.USD","LU0067412154.USD","01093","LU0140636845.USD","IE0008368742.USD","LU1813983027.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","IE0008369823.USD","LU1226287792.SGD","HK0000165453.HKD","BK1521","IE00B031HY20.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1191","LU1226287875.USD","SG9999004220.SGD","LU1993786604.SGD","LU1960683339.HKD","LU1226288170.HKD","LU1226288253.USD","LU1226287529.USD"],"gpt_icon":0},{"id":"2609739158","title":"石药集团02月04日主力净流出7504.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609739158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609739158?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192950,"startTime":"0","endTime":"0","summary":"02月04日, 石药集团股价跌2.02%,报收9.69元,成交金额9.5亿元,换手率0.85%,振幅4.35%,量比0.35。石药集团今日主力资金净流出7504.9万元,上一交易日主力净流入6205.0万元。该股近5个交易日下跌7.68%,主力资金累计净流出3553.1万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入6.1亿元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162105a6d1f32e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162105a6d1f32e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2039709279.SGD","LU1226287792.SGD","LU1226288253.USD","IE00B543WZ88.USD","LU1152091754.HKD","LU0140636845.USD","IE0008368742.USD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU1951186391.HKD","LU1152091168.USD","IE00B031HY20.USD","BK1521","LU1328277881.USD","IE00BZ08YR35.GBP","LU1226287529.USD","BK1191","LU0067412154.USD","LU1008478684.HKD","SG9999004220.SGD","LU0072913022.USD","BK1515","LU1807302812.USD","LU1993786604.SGD","LU1226288170.HKD","LU0315179316.USD","LU0326950275.SGD","LU0501845795.SGD","LU0314109678.HKD","LU0880133367.SGD","IE0008369823.USD","LU1960683339.HKD","LU1813983027.USD","01093","IE00BZ08YT58.USD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2608829585","title":"【券商聚焦】招银国际维持石药集团(01093)“买入”评级 指BD交易将成为盈利增长的关键可持续驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2608829585","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608829585?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:04","pubTimestamp":1770109496,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指,石药集团 与阿斯利康达成战略合作,共同推进八个体重管理和2型糖尿病项目。石药集团报告2025年前9个月总收入为199亿元人民币,其中包含15.4亿元人民币的对外授权收入。剔除BD贡献后,核心收入为184亿元人民币,同比下降19%。得益于近期BD交易的首付款支持,该机构还预计公司将维持可持续的股息派发。维持“买入”评级。石药集团的BD交易将成为盈利增长的关键可持续驱动力。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974494","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.0466},{"period":"1month","weight":0.0306},{"period":"3month","weight":0.2733},{"period":"6month","weight":-0.0634},{"period":"1year","weight":1.2904},{"period":"ytd","weight":0.1993}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0187},{"period":"6month","weight":0.0513},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0365}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.095371},{"month":3,"riseRate":0.483871,"avgChangeRate":0.020489},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013271}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}